 Source: Bukhta Yurii Shutterstock.com NeuroBo NASDAQ: NRBO stock is rising higher on Thursday after the clinical-stage biotechnology company announced a new strategic partnership with Dong-A ST . NeuroBo has entered into a conditional exclusive license agreement that has it agreeing to develop and commercialize DA-1241 and DA-1726. 